Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Aug 6, 2019, after the close
10-Q filed Aug 6, 2019, 37 days after period end · 0001558370-19-007232
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $10.41M | $1.79M | $0.00 | — |
| Net Income | -$20.61M | -$25.56M | -$19.15M | — |
| EPS Diluted |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.12 |
| -$0.16 |
| -$0.16 |
| -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
